Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2013-02-01 Regulatory Filings
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is very short (1654 characters) and begins with 'RNS Number : 6261W'. It announces the 'Total Voting Rights' of the company, stating the total number of ordinary shares with voting rights. This type of mandatory disclosure, often related to changes in share capital or voting power, is typically disseminated via regulatory news services. Since it is a specific regulatory announcement that doesn't fit the definitions for DIRS (Director's Dealing), SHA (Share Issue/Capital Change), or POS (Transaction in Own Shares), and it is clearly an RNS announcement format, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory disclosure provided through the LSE's news service.
2013-02-01 English
Exercise of Options
Share Issue/Capital Change Classification · 99% confidence The document is very short (1586 characters) and begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's RNS service. The content announces the allotment and application for admission to trading of new ordinary shares resulting from the exercise of options. This is a specific corporate action related to share capital. While it involves shares, it is an announcement of a change in the number of shares in issue due to option exercises, which aligns closely with 'Share Issue/Capital Change' (SHA). However, given the explicit mention of 'RNS Number' and the nature of the announcement being a routine regulatory update distributed through the LSE's service, the most fitting general category for such a direct, short regulatory news item that isn't a major financial report is 'Regulatory Filings' (RNS), as it is a direct feed from the exchange service. Since the definitions do not have a specific code for 'Option Exercise/Share Allotment', and it is a direct regulatory news service release, RNS is the appropriate fallback/general regulatory category, although SHA is also highly relevant. Given the structure and source ('RNS Number'), RNS is chosen as the primary classification for this type of immediate regulatory news bulletin.
2013-01-22 English
Group of companies' accounts made up to 2012-06-30
Regulatory Filings
2012-10-19 English
Group of companies' accounts made up to 2011-06-30
Regulatory Filings
2011-12-20 English
Group of companies' accounts made up to 2010-06-30
Regulatory Filings
2010-12-08 English
Group of companies' accounts made up to 2009-06-30
Regulatory Filings
2009-12-08 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.